Kraig Biocraft Laboratories, Inc. (KBLB)
OTCMKTS: KBLB · Delayed Price · USD
0.0918
-0.0023 (-2.39%)
Apr 26, 2024, 3:58 PM EDT - Market closed

KBLB Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2006
Net Income
-3.03-5.56-8.71-5.36-3.2-1.17-2.33-3.07-2.13-1.87
Upgrade
Depreciation & Amortization
0.030.030.030.030.030.030.020.020.020.01
Upgrade
Share-Based Compensation
0.2300.2400000.0300.11
Upgrade
Other Operating Activities
1.533.656.644.072.080.911.582.011.150.85
Upgrade
Operating Cash Flow
-1.24-1.89-1.8-1.25-1.09-0.24-0.73-1.01-0.97-0.9
Upgrade
Capital Expenditures
-0.01-0.01-0.10-0.1-0.01-0.03-0-0.04-0.04
Upgrade
Change in Investments
-5.18--0.45-------
Upgrade
Other Investing Activities
5.18---------
Upgrade
Investing Cash Flow
-0.01-0.01-0.550-0.1-0.01-0.03-0-0.04-0.04
Upgrade
Common Stock Issued
00.740.270.0211,0760.451.030.751.15
Upgrade
Other Financing Activities
-0.062.663.621.930.3-1,075.760.030.05--0
Upgrade
Financing Cash Flow
-0.063.43.891.951.30.240.481.080.751.15
Upgrade
Net Cash Flow
-1.311.511.540.690.11-0-0.280.06-0.260.2
Upgrade
Free Cash Flow
-1.25-1.89-1.9-1.25-1.19-0.25-0.76-1.01-1.01-0.95
Upgrade
Free Cash Flow Margin
------61.36%-781.67%-3183.91%--
Upgrade
Free Cash Flow Per Share
-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.